Dasher-KY
英屬開曼群島商思捷優達(股)公司
Dasher-KY is a Taiwan Emerging Stock Board biotechnology company; its most advanced asset is YA-101 (Phase 2; active not recruiting, Multiple System Atrophy), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| YA-101 | — | Phase 2; active not recruiting | Multiple System Atrophy | Japan, Taiwan, United States | 2026-08-19 | Trial registry |
| YA-102 | — | — | — | — | 2026-07-29 | Company disclosure |
| YA-201 | — | — | — | — | 2026-07-29 | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.